S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
3 Stocks Set to Lead the Nasdaq Bull Market
Norway hits export record amid soaring gas prices
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Stocks end higher on Wall Street; economic worries hit oil
Myanmar executions revive pressure for more sanctions
Is Ford About To Crush Workhorse Group? 
New $2.2 Quadrillion Trend About To Open Up (Ad)pixel
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
3 Stocks Set to Lead the Nasdaq Bull Market
Norway hits export record amid soaring gas prices
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Stocks end higher on Wall Street; economic worries hit oil
Myanmar executions revive pressure for more sanctions
Is Ford About To Crush Workhorse Group? 
New $2.2 Quadrillion Trend About To Open Up (Ad)pixel
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
3 Stocks Set to Lead the Nasdaq Bull Market
Norway hits export record amid soaring gas prices
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Stocks end higher on Wall Street; economic worries hit oil
Myanmar executions revive pressure for more sanctions
Is Ford About To Crush Workhorse Group? 
New $2.2 Quadrillion Trend About To Open Up (Ad)pixel
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
3 Stocks Set to Lead the Nasdaq Bull Market
Norway hits export record amid soaring gas prices
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Stocks end higher on Wall Street; economic worries hit oil
Myanmar executions revive pressure for more sanctions
Is Ford About To Crush Workhorse Group? 
New $2.2 Quadrillion Trend About To Open Up (Ad)pixel
NYSEAMERICAN:MYO

Myomo - MYO Stock Forecast, Price & News

$1.74
+0.04 (+2.35%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.70
$1.76
50-Day Range
N/A
52-Week Range
$1.60
$14.35
Volume
70,640 shs
Average Volume
78,545 shs
Market Capitalization
$12.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.85

Myomo MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
581.0% Upside
$11.85 Price Target
Short Interest
Healthy
0.42% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.12mentions of Myomo in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$12,211 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.52) to ($1.14) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.12 out of 5 stars

MYO stock logo

About Myomo (NYSEAMERICAN:MYO) Stock

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Receive MYO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Myomo and its competitors with MarketBeat's FREE daily newsletter.

MYO Stock News Headlines

What Makes Myomo, Inc. (MYO) a New Strong Buy Stock
Myomo Reports First Quarter 2022 Financial Results
See More Headlines
Receive MYO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Myomo and its competitors with MarketBeat's FREE daily newsletter.

MYO Company Calendar

Last Earnings
11/10/2021
Today
8/16/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:MYO
Fax
N/A
Employees
87
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$11.85
High Stock Price Forecast
$17.00
Low Stock Price Forecast
$6.70
Forecasted Upside/Downside
+581.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-10,370,000.00
Pretax Margin
-65.14%

Debt

Sales & Book Value

Annual Sales
$13.86 million
Book Value
$2.25 per share

Miscellaneous

Free Float
6,839,000
Market Cap
$12.18 million
Optionable
Not Optionable
Beta
1.12














MYO Stock - Frequently Asked Questions

Should I buy or sell Myomo stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Myomo in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MYO shares.
View MYO analyst ratings
or view top-rated stocks.

What is Myomo's stock price forecast for 2022?

3 Wall Street analysts have issued 1-year price objectives for Myomo's stock. Their MYO share price forecasts range from $6.70 to $17.00. On average, they expect the company's share price to reach $11.85 in the next year. This suggests a possible upside of 581.0% from the stock's current price.
View analysts price targets for MYO
or view top-rated stocks among Wall Street analysts.

Are investors shorting Myomo?

Myomo saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 27,100 shares, an increase of 24.9% from the July 15th total of 21,700 shares. Based on an average daily trading volume, of 68,100 shares, the short-interest ratio is currently 0.4 days. Currently, 0.4% of the company's stock are short sold.
View Myomo's Short Interest
.

How were Myomo's earnings last quarter?

Myomo, Inc. (NYSEAMERICAN:MYO) announced its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.36) earnings per share for the quarter, topping analysts' consensus estimates of ($0.46) by $0.10. The firm had revenue of $4.38 million for the quarter, compared to analyst estimates of $3.13 million. Myomo had a negative net margin of 65.87% and a negative trailing twelve-month return on equity of 81.23%.

What guidance has Myomo issued on next quarter's earnings?

Myomo issued an update on its second quarter 2022 earnings guidance on Thursday, July, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $3.40 million-$3.60 million, compared to the consensus revenue estimate of $4.54 million.

What other stocks do shareholders of Myomo own?
What is Myomo's stock symbol?

Myomo trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MYO."

Who are Myomo's major shareholders?

Myomo's stock is owned by a number of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (0.35%). Insiders that own company stock include David A Henry, Paul R Gudonis and Thomas Aloysius Jr Crowley.
View institutional ownership trends
.

How do I buy shares of Myomo?

Shares of MYO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Myomo's stock price today?

One share of MYO stock can currently be purchased for approximately $1.74.

How much money does Myomo make?

Myomo (NYSEAMERICAN:MYO) has a market capitalization of $12.18 million and generates $13.86 million in revenue each year. The company earns $-10,370,000.00 in net income (profit) each year or ($1.71) on an earnings per share basis.

How can I contact Myomo?

Myomo's mailing address is One Broadway, 14Th Floor, CAMBRIDGE, MA 02142, United States. The official website for the company is myomo.com. The company can be reached via phone at (617) 996-9058 or via email at ir@myomo.com.

This page (NYSEAMERICAN:MYO) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.